Le Lézard
Classified in: Health, Science and technology, Business
Subjects: CHI, PDT, LIC, DIS

Vitalxchange Joins Buoy Health's Marketplace to Provide Special Needs and Disability Parenting Solutions


CLEVELAND, July 26, 2022 /PRNewswire/ -- Vitalxchange announced today that it has partnered with Buoy Health to bring its parenting solutions for special needs children to the 2.5M monthly visitors to Buoy's innovative healthcare marketplace.

Digital health innovator Vitalxchange brings its personalized parenting solutions to the Buoy Health platform

"Buoy's marketplace provides Vitalxchange a tremendous opportunity to reach families actively seeking support.  We are excited and honored that Buoy has chosen to partner with us to bring awareness, inclusion, and solutions to families caring for children with special needs and disabilities," said Dr. Charu Ramanathan, Co-founder and CEO of Vitalxchange. 

Vitalxchange is a comprehensive platform for parents that provides content and coaching solutions from qualified pediatric professionals and parent mentors ('VitalGuides'). Based on the child's needs and family profile, Vitalxchange matches the parent to personalized coaching to engage actively in their child's development and care. The platform's unique engagement approach provides continuous support for the family to make informed decisions while reducing the feeling of isolation and helplessness that parents often experience, and to ensure that the overall wellbeing of the family is a priority.

"Our priority as a healthcare matchmaker is to guide people to clinically relevant and timely care sources using our algorithms and medical engine," said Adrienne McFadden, Chief Medical Officer, Buoy Health. "Expanding our marketplace partners with innovative solutions like Vitalxchange allows us to provide a diverse and inclusive range of care options suitable for personalized care matching, while keeping usability top of mind." 

Vitalxchange is currently offering parenting solutions for early developmental delays, autism, behavioral challenges, and learning disabilities through the Buoy marketplace platform.

About Vitalxchange
Vitalxchange is a comprehensive parenting platform for families caring for children with developmental challenges or special needs. Based on each child's needs and family profile, Vitalxchange provides a personalized 'prescription' of actions, content, and coaching to empower parents to engage actively in their child's development. Vitalxchange is actively partnering with family support platforms, employers, schools, and regional disability centers to increase access for families.  For more information, visit www.vitalxchange.com

SOURCE Vitalxchange


These press releases may also interest you

at 03:00
"LASTE" (LArge Stroke Therapy Evaluation), a prospective, randomized, controlled trial co-led by Professor Vincent Costalat (neuroradiologist, Montpellier, France) and Dr. Caroline Arquizan (vascular neurologist,...

at 03:00
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of...

at 03:00
Stratosphere Networks has announced it will sponsor the Anixter Center's annual fundraiser. The Pure Imagination event will take place on Thursday, May 23, from 6 to 9 p.m. at Venue West at 221 N. Paulina St. in Chicago. The Anixter Center provides...

at 02:10
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2023 (period ended March 31, 2024), delivering its Management Guidance for Core Operating Profit and exceeding its Management Guidance for Revenue and Core EPS performance...

8 mai 2024
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...



News published on and distributed by: